Latin America Antifungal Drugs Market by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) by Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) by Application (Powders, Ointments, Drugs, Pastes), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Antifungal Drugs Market by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) by Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) by Application (Powders, Ointments, Drugs, Pastes), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 248 | Pages: 130 | December 2016 | Region: Latin America


The Latin America Antifungal Drugs Market was worth $1.72 billion in 2015 and estimated to be growing at a CAGR of 3.7%, to reach $2.07 billion by 2020. In the next few years, the market is expected to grow enormously with the growing global population.

Antifungal drugs are used commonly for curing fungal infections occurring due to, unclean, unhygienic and damp environment. Invasion of epithelial tissue by microscopic organisms lead to fungal infections. Systemic fungal infections are those caused due to indigestion or inhalation of spores, leading to fungal pneumonia and diseases like candidaisis, meningitis, mucormycosis, etc. are caused by opportunistic fungus. Although majority of the fungal infections and diseases are commonly non-lethal, they are very uncomforting to the host and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting of cell wall formation, cell membrane disruption and cell division.

The major factors driving the market are rising awareness of fungal infections with the increasing incidence of antifungal infections all over the world, rising government and corporate funding in the industry. Further, more and more development of public private partnership in the pharmaceutical industry and the rising popularity of over-the-counter antifungal drugs for dermal infections is vastly responsible for the increasing the market size. Also, the increase of population with weak, in whom the occurrence of fungal infections is much more than average, will drive the market. Existing high penetration of conventional drugs used for the treatment of fungal infections is restraining the Latin America Antifungal drugs market’s growth.

The key challenges faced by the Latin America Antifungal drugs market are cost of drugs and their effectiveness in treatments. In Latin America, with the presence of high income countries like Argentina and Upper-middle income countries like Brazil, the antifungal drugs market in the region is going to grow fastest.

The antifungal drugs market is segmented on the basis of drug type into 1. Echinocandins, 2. Azoles, 3. Polyenes, 4. Allylamines and 5. Other Drugs, by type of therapeutic indications into 1. Aspergillosis, 2. Dermatophytosis, 3. Candidiasis and 4. Other therapeutic indications, by applications into 1. Powders, 2. Ointments, 3. Drugs and 4. Pastes. While Azoles (fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole) are systemically acting, Echinocandins (anidulafungin, caspofungin and micafungin) are lipopeptides derived from natural fungal fermentation products and Polyenes (amphotericin B deoxycholate and liposomal amphotericin B. Corifungin) are systemically acting and disrupt eukaryotic cellular membranes. Azoles Antifungal Drugs segment is the largest segment of the market followed by echinocandins.

On the basis of geography, the Latin America Antifungal Drugs market is segmented into Brazil, Argentina, Mexico, Rest of Latin America. The antifungal drugs market in Latin America is second fast growing market following Asia-Pacific. Increase in Health expenditure is the major driver for the market in the region.

The major companies dominating the market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories to name few.

 

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 Brazil

                                6.3 Argentina

                                6.4 Mexico

                                6.5 Rest of Latin America

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. Latin America Antifungal Drugs Market By Region, From 2015-2020 (USD Million)
  2. Latin America Antifungal Drugs Market By Drug Type, From 2015-2020 (USD Million)
  3. Latin America Echinocandins Market By Region, From 2015-2020 (USD Million)
  4. Latin America Azoles Market By Region, From 2015-2020 (USD Million)
  5. Latin America Polyenes Market By Region, From 2015-2020 (USD Million)
  6. Latin America Allylamines Market By Region, From 2015-2020 (USD Million)
  7. Latin America Other Drugs Market By Region, From 2015-2020 (USD Million)
  8. Latin America Antifungal Drugs Market By Therapeutic Indications, From 2015-2020 (USD Million)
  9. Latin America Aspergillosis Market By Region, From 2015-2020 (USD Million)
  10. Latin America Dermatophytosis Market By Region, From 2015-2020 (USD Million)
  11. Latin America Candidiasis Market By Region, From 2015-2020 (USD Million)
  12. Latin America Other Therapeutic Indications Market By Region, From 2015-2020 (USD Million)
  13. Latin America Antifungal Drugs Market By Application, From 2015-2020 (USD Million)
  14. Latin America Powders Market By Region, From 2015-2020 (USD Million)
  15. Latin America Ointments Market By Region, From 2015-2020 (USD Million)
  16. Latin America Drugs Market By Region, From 2015-2020 (USD Million)
  17. Latin America Pastes Market By Region, From 2015-2020 (USD Million)
  18. Brazil Antifungal Drugs Market By Drug Type, From 2015-2020 (USD Million)
  19. Brazil Antifungal Drugs Market By Therapeutic Indications, From 2015-2020 (USD Million)
  20. Brazil Antifungal Drugs Market By Application, From 2015-2020 (USD Million)
  21. Argentina Antifungal Drugs Market By Drug Type, From 2015-2020 (USD Million)
  22. Argentina Antifungal Drugs Market By Therapeutic Indications, From 2015-2020 (USD Million)
  23. Argentina Antifungal Drugs Market By Application, From 2015-2020 (USD Million)
  24. Mexico Antifungal Drugs Market By Drug Type, From 2015-2020 (USD Million)
  25. Mexico Antifungal Drugs Market By Therapeutic Indications, From 2015-2020 (USD Million)
  26. Mexico Antifungal Drugs Market By Application, From 2015-2020 (USD Million)
  27. Rest of Latin America Antifungal Drugs Market By Drug Type, From 2015-2020 (USD Million)
  28. Rest of Latin America Antifungal Drugs Market By Therapeutic Indications, From 2015-2020 (USD Million)
  29. Rest of Latin America Antifungal Drugs Market By Application, From 2015-2020 (USD Million)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.